Kishor M. Wasan

9.7k total citations · 1 hit paper
238 papers, 7.6k citations indexed

About

Kishor M. Wasan is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Kishor M. Wasan has authored 238 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 47 papers in Surgery and 44 papers in Oncology. Recurrent topics in Kishor M. Wasan's work include Antifungal resistance and susceptibility (34 papers), Cholesterol and Lipid Metabolism (32 papers) and Drug Transport and Resistance Mechanisms (30 papers). Kishor M. Wasan is often cited by papers focused on Antifungal resistance and susceptibility (34 papers), Cholesterol and Lipid Metabolism (32 papers) and Drug Transport and Resistance Mechanisms (30 papers). Kishor M. Wasan collaborates with scholars based in Canada, United States and United Kingdom. Kishor M. Wasan's co-authors include Ellen K. Wasan, Gabriel Lopez‐Berestein, Kristina Sachs‐Barrable, Olena Sivak, Pavel Gershkovich, Panayiotis P. Constantinides, Carlos León, P. Haydn Pritchard, Manisha Ramaswamy and Stephen D. Lee and has published in prestigious journals such as Journal of Clinical Investigation, Biomaterials and Nature Reviews Drug Discovery.

In The Last Decade

Kishor M. Wasan

235 papers receiving 7.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery

2017 982 citations Kishor M. Wasan, Ellen K. Wasan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kishor M. Wasan Canada	45	2.1k	1.5k	1.1k	952	885	238	7.6k
Patrick J. Sinko United States	54	2.8k 1.3×	1.5k 1.0×	1.2k 1.2×	2.2k 2.3×	713 0.8×	177	8.0k
Jianping Zhou China	34	2.4k 1.2×	1.1k 0.8×	694 0.7×	1.0k 1.1×	174 0.2×	180	7.5k
Sanjay Jain India	64	3.4k 1.7×	3.8k 2.5×	2.5k 2.4×	633 0.7×	517 0.6×	461	14.5k
Donald W. Miller United States	50	2.2k 1.1×	667 0.4×	1.8k 1.7×	2.0k 2.1×	319 0.4×	155	7.8k
Gert Fricker Germany	56	3.3k 1.6×	2.1k 1.4×	1.3k 1.2×	4.2k 4.4×	583 0.7×	258	10.6k
Salette Reis Portugal	63	4.8k 2.4×	2.7k 1.8×	1.9k 1.8×	727 0.8×	352 0.4×	332	13.5k
Pieter Annaert Belgium	49	1.3k 0.7×	1.9k 1.3×	394 0.4×	1.9k 2.0×	1.1k 1.3×	237	7.6k
Ronald T. Borchardt United States	60	7.0k 3.4×	1.6k 1.1×	492 0.5×	3.0k 3.1×	935 1.1×	318	13.7k
Peter W. Swaan United States	44	2.9k 1.4×	499 0.3×	787 0.7×	2.2k 2.3×	363 0.4×	129	6.9k
Jia‐You Fang Taiwan	61	3.4k 1.6×	4.3k 2.9×	1.6k 1.5×	415 0.4×	268 0.3×	333	13.0k

Countries citing papers authored by Kishor M. Wasan

Since Specialization

Citations

This map shows the geographic impact of Kishor M. Wasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kishor M. Wasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kishor M. Wasan more than expected).

Fields of papers citing papers by Kishor M. Wasan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kishor M. Wasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kishor M. Wasan. The network helps show where Kishor M. Wasan may publish in the future.

Co-authorship network of co-authors of Kishor M. Wasan

This figure shows the co-authorship network connecting the top 25 collaborators of Kishor M. Wasan. A scholar is included among the top collaborators of Kishor M. Wasan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kishor M. Wasan. Kishor M. Wasan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gallini, Nancy, et al.. (2023). Implementation and impact of the global access principles at the University of British Columbia: current successes and future challenges. Frontiers in Pharmacology. 14. 1271618–1271618.

Aibani, Noorjahan, Parth Patel, Rachelle Buchanan, et al.. (2022). Assessing the In Vivo Effectiveness of Cationic Lipid Nanoparticles with a Triple Adjuvant for Intranasal Vaccination against the Respiratory Pathogen Bordetella pertussis. Molecular Pharmaceutics. 19(6). 1814–1824. 7 indexed citations

Gyorkos, Theresa W., Hélène Carabin, Janet Hatcher Roberts, et al.. (2021). Canadian contributions to research on neglected tropical diseases. PLoS neglected tropical diseases. 15(7). e0009476–e0009476. 3 indexed citations

Gordon, Jacob A., Ankur Midha, Fatemeh Derakhshan, et al.. (2019). Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer. Cancer Research. 79(13). 3320–3331. 46 indexed citations

Wasan, Ellen K., et al.. (2015). Lipid-lowering Activity of Natural and Semi-Synthetic Sterols and Stanols. Journal of Pharmacy & Pharmaceutical Sciences. 18(4). 344–344. 21 indexed citations

Kagan, Leonid, Pavel Gershkovich, Kishor M. Wasan, & Donald E. Mager. (2011). Physiologically Based Pharmacokinetic Model of Amphotericin B Disposition in Rats Following Administration of Deoxycholate Formulation (Fungizone®): Pooled Analysis of Published Data. The AAPS Journal. 13(2). 255–64. 25 indexed citations

Thornton, Sheila J. & Kishor M. Wasan. (2009). The reformulation of Amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis. Expert Opinion on Drug Delivery. 6(3). 271–284. 40 indexed citations

Wasan, Kishor M., Sheila J. Thornton, Ian H. Bell, et al.. (2008). The Global Access Initiative at the University of British Columbia (UBC): Availability of UBC Discoveries and Technologies to the Developing World. Journal of Pharmaceutical Sciences. 98(3). 791–794. 8 indexed citations

Locke, Jennifer A., Kishor M. Wasan, Emma S. Tomlinson Guns, Colleen C. Nelson, & Carlos León. (2007). Upregulation of STAT1 transcription activator by an androgen agonist in prostate cancer cells affects intracellular cholesterol esterification. Cancer Research. 67. 1 indexed citations

10.

Wasan, Kishor M., et al.. (2006). Role of Phospholipid Transfer Protein on the Plasma Distribution of Amphotericin B Following the Incubation of Different Amphotericin B Formulations. Pharmaceutical Research. 23(5). 1020–1024. 2 indexed citations

11.

Raalte, Daniël H. van, Min Li, P. Haydn Pritchard, & Kishor M. Wasan. (2004). Peroxisome Proliferator-Activated Receptor (PPAR)-α: A Pharmacological Target with a Promising Future. Pharmaceutical Research. 21(9). 1531–1538. 223 indexed citations

12.

Risovic, Verica, Michael Boyd, Eugene Choo, & Kishor M. Wasan. (2003). Effects of Lipid-Based Oral Formulations on Plasma and Tissue Amphotericin B Concentrations and Renal Toxicity in Male Rats. Antimicrobial Agents and Chemotherapy. 47(10). 3339–3342. 43 indexed citations

13.

Wasan, Kishor M., et al.. (2002). Amphotericin B interactions with a DOPC monolayer. Electrochemical investigations. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1564(1). 289–297. 16 indexed citations

14.

Lundberg, B., Verica Risovic, Manisha Ramaswamy, & Kishor M. Wasan. (2002). A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. Journal of Controlled Release. 86(1). 93–100. 101 indexed citations

15.

Sivak, Olena, et al.. (2001). Cyclosporine A transfer between high‐ and low‐density lipoproteins: Independent from lipid transfer protein I‐facilitated transfer of lipoprotein‐coated phospholipids because of high affinity of cyclosporine a for the protein component of lipoproteins. Journal of Pharmaceutical Sciences. 90(9). 1308–1317. 8 indexed citations

16.

Wasan, Kishor M., et al.. (1996). Decreases in high density lipoprotein esterified cholesterol content alters the plasma distribution of annamycin and nystatin. 260. 1 indexed citations

17.

Wasan, Kishor M. & Gabriel Lopez‐Berestein. (1994). Modification of Amphotericin B's Therapeutic Index by Increasing Its Association with Serum High‐Density Lipoproteinsa. Annals of the New York Academy of Sciences. 730(1). 93–106. 8 indexed citations

18.

Wasan, Kishor M., Richard E. Morton, Michael G. Rosenblum, & Gabriel Lopez‐Berestein. (1994). Decreased Toxicity of Liposomal Amphotericin B Due to Association of Amphotericin B with High‐Density Lipoproteins. Journal of Pharmaceutical Sciences. 83(7). 1006–1010. 71 indexed citations

19.

Luke, David R., Kishor M. Wasan, Regina Verani, et al.. (1991). Attenuation of Amphotericin-B Nephrotoxicity in the Candidiasis Rat Model. The Nephron journals/Nephron journals. 59(1). 139–144. 8 indexed citations

20.

Berens, Kurt L., Kiumars Vadiei, Lane J. Brunner, Kishor M. Wasan, & David R. Luke. (1990). Influence of lovastatin on the pharmacokinetics, toxicity and immunologic response of cyclosporine in the obese zucker rat. Biopharmaceutics & Drug Disposition. 11(3). 197–206. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact